Across TCGA pan-cancer cohorts, DAPK1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated DAPK1 data layer compared with 27 for mass-spec protein and 10 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher DAPK1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated DAPK1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and CCRCC show a favorable association.

UCEC, CCRCC, and LUAD are the cancer types where DAPK1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	III,IV	1.000	0.494	.016	18	view →
CCRCC	OS	Median	All	0.958	0.829	.015	10	view →
LUAD	OS	Tertile	All	1.000	0.937	.038	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: DAPK1 tumor-vs-normal RNA expression · all DAPK1 data types